Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05064852 | A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma | unknown | — | 200 | Qilu Hospital of Shandong UniversityOTHER | 0 | Oct 1, 2021 | clinicaltrials |
| NCT03469726 | Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer(DIA-PANC) | unknown | N/A | 465 | Radboud University Medical CenterOTHER | 4 | Sep 21, 2021 |
| clinicaltrials |
| NCT04652271 | International Pancreatic Surgery Outcomes Study - PancreasGroup.Org | unknown | — | 3,500 | Royal Free Hospital NHS Foundation TrustOTHER | 0 | Sep 16, 2021 | clinicaltrials |
| NCT03603834 | Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma | unknown | Phase 2 | 25 | Khon Kaen UniversityOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT04928625 | A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer | unknown | Phase 1 | 75 | Shanghai Hengrui Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 24, 2021 | clinicaltrials |
| NCT04549064 | Biomarkers of Pancreatic Cancer and New Way to Detection | unknown | — | 600 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 23, 2021 | clinicaltrials |
| NCT04718701 | Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer(ATNPA) | unknown | Phase 2 | 53 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 16, 2021 | clinicaltrials |
| NCT02305186 | Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer(UVA-PC-PD101) | unknown | Phase 1 / Phase 2 | 68 | Craig L Slingluff, JrOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04979663 | GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer | unknown | Phase 1 / Phase 2 | 10 | Fudan UniversityOTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04993846 | Pancreatic Cancer and Oral Microbiome | unknown | — | 120 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT03528785 | A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer(nITRo) | unknown | Phase 2 | 67 | Centro Ricerche Cliniche di VeronaOTHER | 1 | Aug 2, 2021 | clinicaltrials |
| NCT04337333 | Two-in-one Covered and Uncovered Metal Stent | unknown | N/A | 100 | Ajou University School of MedicineOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT04966143 | Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer | unknown | Early Phase 1 | 30 | Shanghai Longyao Biotechnology Inc., Ltd.OTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04779788 | I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma | unknown | N/A | 100 | Xuzhou Central HospitalOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04961788 | Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04961970 | HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | unknown | Phase 3 | 188 | Shi MingOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT03951597 | Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT01676259 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer(PROTACT) | unknown | Phase 2 | 80 | Silenseed LtdINDUSTRY | 2 | Jul 2, 2021 | clinicaltrials |
| NCT04947696 | Circulating Epigenetics in Pancreatic Surgery | unknown | — | 200 | Rigshospitalet, DenmarkOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04140552 | Chinese Research Group of Gallbladder Cancer(CRGGC) | unknown | — | 10,000 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT04623749 | Percutaneous Versus EUS FNAC in Pancreatic Masses | unknown | N/A | 50 | Ola Kamal Mohammed GalalOTHER | 0 | Jun 14, 2021 | clinicaltrials |
| NCT04922515 | Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes(PDA-MAPS) | unknown | N/A | 200 | University Medical Center GoettingenOTHER | 1 | Jun 10, 2021 | clinicaltrials |
| NCT04907864 | Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE)(MIRACLE) | unknown | Phase 2 | 112 | Kil Yeon LeeOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04814485 | Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer | unknown | Phase 2 | 39 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 25, 2021 | clinicaltrials |
| NCT04897854 | Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer(TIMEPAN) | unknown | Phase 3 | 184 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | May 24, 2021 | clinicaltrials |
| NCT04892927 | NCI SBIR Contract for Patient Navigation Tool Prototype Development | unknown | — | 25 | GMG Arcdata LLCINDUSTRY | 1 | May 19, 2021 | clinicaltrials |
| NCT03865875 | Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program | unknown | N/A | 40 | Massachusetts General HospitalOTHER | 1 | May 17, 2021 | clinicaltrials |
| NCT04628806 | Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells(HSP70CTC) | unknown | — | 120 | Charite University, Berlin, GermanyOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT04877340 | Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions | unknown | N/A | 50 | Instituto do Cancer do Estado de São PauloOTHER | 1 | May 7, 2021 | clinicaltrials |
| NCT03679169 | Evaluation of Complete microscopicE Resection Margin (R0) and Lymph Node Involvement After Standard Pancreatosplenectomy (SPS) Versus Radical Anterograde Modular Pancreatosplenectomy(REMIND-01) | unknown | N/A | 260 | Institut Paoli-CalmettesOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT03959150 | Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 231 | Ruijin HospitalOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT03620292 | Fluorescence Image Guided Surgery in Cholangiocarcinoma(COUGAR) | unknown | Phase 1 / Phase 2 | 12 | University Medical Center GroningenOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT04843956 | Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic Lesions | unknown | N/A | 41 | Hospital Universitario Dr. Jose E. GonzalezOTHER | 1 | Apr 14, 2021 | clinicaltrials |
| NCT04840537 | Cholangioscopy or Conventional Techniques for Indeterminate Biliary Stenosis | unknown | N/A | 150 | Frederic PRAT, MD, PhDOTHER | 1 | Apr 12, 2021 | clinicaltrials |
| NCT04211948 | Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer | unknown | N/A | 300 | Ruijin HospitalOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04707560 | Heparin-based Wet Suction Method in EUS Fine Needle Biopsy of Solid Pancreatic Mass | unknown | N/A | 50 | National Cheng-Kung University HospitalOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04835064 | Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. | unknown | Phase 3 | 600 | Fudan UniversityOTHER | 0 | Apr 8, 2021 | clinicaltrials |
| NCT04093141 | Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer(CHEMOFIRE-2) | unknown | N/A | 30 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04813432 | Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas | unknown | — | 50 | Karolinska InstitutetOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT04814251 | Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study(THROMPAN) | unknown | — | 200 | Poitiers University HospitalOTHER | 0 | Mar 24, 2021 | clinicaltrials |
| NCT04808687 | Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer | unknown | Phase 2 | 72 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 22, 2021 | clinicaltrials |
| NCT04809935 | EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy | unknown | Phase 4 | 54 | The University of Hong KongOTHER | 1 | Mar 22, 2021 | clinicaltrials |
| NCT03140592 | Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue | unknown | — | 300 | Stony Brook UniversityOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT04739046 | An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | unknown | Phase 2 | 12 | Seoul National University Bundang HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04794140 | A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC | unknown | N/A | 60 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT04783831 | Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy | unknown | — | 60 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT04783844 | Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic Tumors | unknown | — | 60 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT04584996 | CIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary Cancers(CIRCUS) | unknown | — | 186 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04777604 | Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid | unknown | — | 300 | Samsung Medical CenterOTHER | 1 | Mar 2, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Oct 1, 2021source: clinicaltrials